经皮穿刺冠状动脉介入疗法的非心脏并发症的诊治

为评价经皮冠状动脉介入疗法的非心脏并发症的诊断和治疗效果 ,对 4 4 35例次经股动脉介入诊疗术后发生的非心脏并发症进行分析。结果 :非心脏并发症的总发生率为 1.3% (5 7/44 35 ) ,其中穿刺部位严重外出血 0 .0 9% (4/44 35 ) ,腹膜后血肿 0 .0 2 % (1/44 35 ) ,假性动脉瘤 0 .9% (40 /44 35 ) ,肺动脉栓塞 0 .0 2 % (1/44 35 ) ,紫趾综合征 0 .0 5 % (2 /44 35 ) ,股动脉夹层 0 .0 7% (3/44 35 ) ,股动脉穿孔 0 .0 2 % (1/44 35 ) ,造影剂过敏性休克 0 .0 5 % (2 /44 35 ) ,脑卒中 0 .0 5 %(2 /44 35 ) ,股动脉血栓形成 0 .0 2 % (1/44 35 )。仅死亡 1例 (肺动脉栓塞 ) ,占 0 .0 2 % (1/44 35 ) ,其余病例经处理未留后遗症。提示 :经皮冠状动脉介入诊疗的非心脏并发症并非少见 ,如能及时发现、做出诊断并采取相应的处理 ,一般预后良好。

Diagnosis and Treatment of Noncardiac Complication Following Angiograph and Angioplasty

The ai m was to evaluate the diagnosis and treatment of non-cardiac complications foll owing coronary interventional procedure. Non-cardiac complications of 4 435 pat ie nts underwent cardiac intervention were analysed. It find that the total noncard iac complications rate was 1.3%, including severe external hemo rrhage 0.09%, retroperitoneal hematoma 0.02%, femoral pseudoaneurysm 0 .9%, pulmo nary thromboembolism 0.02%, blue toe syndrome 0.05%, femoral dissection 0.07 %, femoral penetration 0.02 %, severe contrast allergic shock 0.05%, stroke 0.05%, femoral thrombus 0.02 %. D eath occurred in 1 patients due to pulmonary thromboembolism after one day of an giograpm, and no sequela occurred in other patients. It suggests that Non-cardi ac c omplications following coronary interventional procedure through femoral artery are common and have good results after immediate diagnosis and treatment.